These pathways are known to be aberrantly activated in breast cancers.[43, 44, 45] Meanwhile, the genes exhibiting the greatest differential expression in H1 are BGN, which is the most upregulated, and KRT19, the most downregulated (Figure 3I). This evidence concerns the gene KRT19 and breast carcinoma.